Citius Oncology, Inc. (CTOR) Net income 2022–2025
Citius Oncology, Inc. (CTOR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$24.8MFY2025 · since FY2022: $380,811 → -$24.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.8M | -17.1% |
| FY2024 | -$21.1M | -974.2% |
| FY2023 | $2.4M | +535.3% |
| FY2022 | $380,811 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTOR financial trends
CTOR RevenueCTOR Net marginCTOR Gross profitCTOR Gross marginCTOR Operating incomeCTOR Operating marginCTOR Operating cash flowCTOR Free cash flowCTOR Capital expendituresCTOR Return on equityCTOR Stock buybacksCTOR Dividends paidCTOR Total assetsCTOR Total liabilitiesCTOR Shareholders’ equityCTOR overview →